Camlin Fine Sciences Limited has informed the Exchange about change in Management
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camlin Fine Sciences reported Q1FY26 results with standalone revenue of Rs. 191.4 crore, up 5% YoY, and a net loss of Rs. 10.68 crore versus Rs. 13.68 crore loss in Q1FY25. Consolidated revenue rose 11% YoY to Rs. 423.6 crore with a narrower net loss of Rs. 6.43 crore. The board approved the re-appointment of Mr. Joseph Conrad D'Souza as a Non-Executive Independent Director for a second 5-year term from September 29, 2025, subject to shareholder approval via postal ballot. Mr. Hari Rajmohan was appointed as an Alternate Director to a non-executive director for August 8, 2025. Mr. Amarsinh Jadhavrao, Chief Executive (HR & Corporate Affairs), resigned, and the CFO Mr. Santosh Parab was given interim ad hoc charge of the HR and Administration department until a successor is appointed.
The Q1 numbers show modest top-line growth but persistent losses on both standalone and consolidated bases, keeping sentiment cautious. The KMP-level exit in HR is being managed internally by the CFO, limiting disruption, while the re-appointment of a seasoned independent director supports board continuity.